Skip to content
Search

Latest Stories

Minister Zahawi says he is confident to achieve UK's 'herculean' vaccine target

Minister Zahawi says he is confident to achieve UK's 'herculean' vaccine target

BRITISH prime minister Boris Johnson's 'herculean' aim to vaccinate around 14 million of the most vulnerable people against Covid-19 by the middle of next month is achievable, his vaccine minister said on Wednesday(6).

As major powers eye the benefits of being first out of the pandemic, Britain is rushing to vaccinate its population faster than the US and the rest of Europe, although Russia and China have been inoculating their citizens for months.


The vaccine is seen as the main way out of the Covid-19 crisis which has killed 1.87 million people, destroyed whole swathes of the global economy and upended normal life for billions of people across the world.

Johnson has set a target of vaccinating the elderly, including care home residents, the clinically vulnerable and frontline workers - around 14 million people - by mid-February.

Asked if it was achievable to vaccinate 14 million people by the middle of February and 2 million vaccinations each week by the end of this month, minister for Covid Vaccine Deployment Nadhim Zahawi said it was.

"It is a Herculean effort," he told Sky, adding that it was stretching but deliverable. He said that 1/4 of people over 80 years old had been vaccinated with their first shot.

More than 1.3 million people in the UK have been vaccinated against Covid-19.

Britain, grappling with the world's fifth worst death toll and one of the worst economic hits from the Covid crisis, was the first country to roll out the vaccine developed by Pfizer and Germany's BioNTech just under a month ago.

The UK this week became the first country in the world to start deploying the vaccine developed by AstraZeneca and Oxford University.

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
Gen Z

These terms provide insight into how Gen Z views the world around them

iStock

11 Gen Z slang terms that have already peaked in 2025

Language is constantly evolving, and nowhere is this more apparent than in the lexicon of Gen Z. As the first generation to grow up fully immersed in social media, their language is influenced by memes, viral videos, and digital culture. With 2025 underway, several Gen Z slang terms have already become ubiquitous, appearing in everyday conversations, on social media platforms, and even in mainstream media. Here are 11 slang terms that have already peaked this year.

1. Delulu

"Delulu," short for "delusional," is one of the most prominent slang terms of 2025. It’s used to describe someone who holds unrealistic beliefs or makes outlandish claims. The term was catapulted into the spotlight after Australian Prime Minister Anthony Albanese used it in Parliament to describe his political opponents, referring to them as being "delulu with no solulu," which translates to "delusional with no solution." The term has since been widely adopted by young people, particularly in online communities. It’s now frequently used to poke fun at someone’s exaggerated or disconnected views on social media.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less